Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease-Reference-Cited by-同舟云学术

Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease

Published:2014-03-03 Issue:6 Volume:10 Page:743
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Lim Yen Ying¹²,Maruff Paul¹³,Pietrzak Robert H.⁴,Ellis Kathryn A.¹⁵⁶,Darby David¹,Ames David⁵⁶,Harrington Karra¹,Martins Ralph N.⁷,Masters Colin L.¹,Szoeke Cassandra¹⁶⁸,Savage Greg⁹,Villemagne Victor L.¹¹⁰¹¹,Rowe Christopher C.¹⁰¹¹,

Affiliation:

1. The Florey Institute of Neuroscience and Mental HealthParkvilleVictoriaAustralia

2. Department of PsychiatryThe University of MelbourneParkvilleVictoriaAustralia

3. CogState Ltd.MelbourneVictoriaAustralia

4. Department of PsychiatryYale University School of MedicineNew HavenCTUSA

5. Academic Unit for Psychiatry of Old Age, Department of PsychiatryThe University of MelbourneKewVictoriaAustralia

6. National Ageing Research InstituteParkvilleVictoriaAustralia

7. Centre of Excellence for Alzheimer's Disease Research and CareSchool of Exercise, Biomedical, and Health Sciences, Edith Cowan UniversityPerthWestern AustraliaAustralia

8. CSIRO Preventative Health FlagshipParkvilleVictoriaAustralia

9. Department of Psychology and ARC Centre of Excellence in Cognition and Its DisordersMacquarie UniversitySydneyNew South WalesAustralia

10. Department of Nuclear Medicine and Centre for PETAustin HealthHeidelbergVictoriaAustralia

11. Department of MedicineAustin Health, The University of MelbourneHeidelbergVictoriaAustralia

Funder

Commonwealth Scientific and Industrial Research Organisation

Edith Cowan University

Campbell Family Mental Health Research Institute

Alzheimer's Australia

Hollywood Private Hospital Research Foundation

CSIRO

Mental Health Research Institute

National Ageing Research Institute

Austin Health

CogState, Ltd.

Hollywood Private Hospital

Sir Charles Gardner Hospital

National Health and Medical Research Council

Dementia Collaborative Research Centres program

Science and Industry Endowment Fund

Eli Lilly and Company

GlaxoSmithKline

Forest Laboratories, Inc.

Novartis

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2013.11.005

Reference33 articles.

1. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

2. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

3. -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

4. Prediction of cognitive decline by positron emission tomography of brain amyloid and tau;Small G.W.;Arch Neurol,2012

5. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity;Alzheimer's Research & Therapy;2024-08-19

2. The long term effects of uncoupling interventions as a therapy for dementia in humans;Journal of Theoretical Biology;2024-06

3. Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study;The Journal of Prevention of Alzheimer's Disease;2024

4. Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-12-06

5. Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects.;Neuropsychology;2023-09